These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941 [TBL] [Abstract][Full Text] [Related]
64. FB1, a monoclonal antibody reacting with a keratin 14 epitope, stains only a small subset of psoriatic basal keratinocytes. Parent D; Golstein J; Mairesse N; Bernerd F; Faverly D; Robben H; Ramaekers F; Heenen M Cell Prolif; 1994 Mar; 27(3):165-76. PubMed ID: 10465007 [TBL] [Abstract][Full Text] [Related]
65. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours. Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461 [TBL] [Abstract][Full Text] [Related]
66. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079 [TBL] [Abstract][Full Text] [Related]
67. Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas. Rubina KA; Sysoeva VY; Zagorujko EI; Tsokolaeva ZI; Kurdina MI; Parfyonova YV; Tkachuk VA Arch Dermatol Res; 2017 Aug; 309(6):433-442. PubMed ID: 28429105 [TBL] [Abstract][Full Text] [Related]
68. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors. Kanoh M; Amoh Y; Sato Y; Katsuoka K Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153 [TBL] [Abstract][Full Text] [Related]
69. Expression of drebrin, an actin binding protein, in basal cell carcinoma, trichoblastoma and trichoepithelioma. Mizutani Y; Iwamoto I; Kanoh H; Seishima M; Nagata K Histol Histopathol; 2014 Jun; 29(6):757-66. PubMed ID: 24346822 [TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors. Barbaud A; Simon M; Parache RM; Serre G Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887 [TBL] [Abstract][Full Text] [Related]
71. Some further features for differential diagnosis between squamous cell carcinomas and basal cell epitheliomas. Tosca A; Varelzidis A; Bassioukas K; Hatzis J; Nicolis G; Stratigos J Dermatologica; 1985; 171(1):21-6. PubMed ID: 2411609 [TBL] [Abstract][Full Text] [Related]
72. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions. Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511 [TBL] [Abstract][Full Text] [Related]
74. [Elevated p53 protein expression in normal and neoplastic light-exposed epidermis]. Sutter C; Wersin R; Varnai M; Friemann J Verh Dtsch Ges Pathol; 1994; 78():246-51. PubMed ID: 7533993 [TBL] [Abstract][Full Text] [Related]
75. Use of a monoclonal antibody (VM-2) plus the immunogold-silver technique to stain basal cell carcinoma cells. Morhenn VB; Roth S; Roth R J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):765-9. PubMed ID: 2445798 [TBL] [Abstract][Full Text] [Related]
76. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903 [TBL] [Abstract][Full Text] [Related]